Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References

Annpey Pong,1 Susan S Chow,2 Shein-Chung Chow3 1Biostatistics, Merck & Co Inc., Rahway, NJ, USA; 2Internal Medicine, The Wright Center for Community Health, Scranton, PA, USA; 3Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USACorrespondence: Annp...

Full description

Saved in:
Bibliographic Details
Main Authors: Pong A, Chow SS, Chow SC
Format: Article
Language:English
Published: Dove Medical Press 2024-12-01
Series:Biologics: Targets & Therapy
Subjects:
Online Access:https://www.dovepress.com/comparison-of-innovative-and-conventional-methods-in-biosimilar-bridgi-peer-reviewed-fulltext-article-BTT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136664261394432
author Pong A
Chow SS
Chow SC
author_facet Pong A
Chow SS
Chow SC
author_sort Pong A
collection DOAJ
description Annpey Pong,1 Susan S Chow,2 Shein-Chung Chow3 1Biostatistics, Merck & Co Inc., Rahway, NJ, USA; 2Internal Medicine, The Wright Center for Community Health, Scranton, PA, USA; 3Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USACorrespondence: Annpey Pong, Biostatistics, Merck & Co Inc., Rahway, NJ, USA, Email annpey.pong@merck.comAbstract: For assessment of biosimilar drug products, if there are multiple-reference products (eg, a US-licensed product and an EU-approved product), a biosimilar bridging study with a 3-way pairwise comparison is often conducted. In our paper, two innovative methods in biosimilar bridging study are compared with the conventional method of pairwise comparisons. For parallel study design, the simultaneous confidence interval (CI) method is compared to the convention method. For crossover study design, the multiplicity-adjusted Schuirmann’s two one-sided tests (MATOST) is considered. This paper conclude that the simultaneous CI method achieves the similar statistical power to the conventional approach in biosimilarity assessment. However, the MATOST method using the conservative Holm and Bonferroni approaches is not favorable since it leads to a large sample size although it controls the type I error rate.Keywords: bioequivalence and biosimilarity, multiple references, simultaneous confidence interval approach, multiplicity-adjusted two one-sided tests, MATOST
format Article
id doaj-art-5c621ad8f25d4192b1851e86af2e496f
institution Kabale University
issn 1177-5491
language English
publishDate 2024-12-01
publisher Dove Medical Press
record_format Article
series Biologics: Targets & Therapy
spelling doaj-art-5c621ad8f25d4192b1851e86af2e496f2024-12-08T17:58:37ZengDove Medical PressBiologics: Targets & Therapy1177-54912024-12-01Volume 1837738798035Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple ReferencesPong AChow SSChow SCAnnpey Pong,1 Susan S Chow,2 Shein-Chung Chow3 1Biostatistics, Merck & Co Inc., Rahway, NJ, USA; 2Internal Medicine, The Wright Center for Community Health, Scranton, PA, USA; 3Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USACorrespondence: Annpey Pong, Biostatistics, Merck & Co Inc., Rahway, NJ, USA, Email annpey.pong@merck.comAbstract: For assessment of biosimilar drug products, if there are multiple-reference products (eg, a US-licensed product and an EU-approved product), a biosimilar bridging study with a 3-way pairwise comparison is often conducted. In our paper, two innovative methods in biosimilar bridging study are compared with the conventional method of pairwise comparisons. For parallel study design, the simultaneous confidence interval (CI) method is compared to the convention method. For crossover study design, the multiplicity-adjusted Schuirmann’s two one-sided tests (MATOST) is considered. This paper conclude that the simultaneous CI method achieves the similar statistical power to the conventional approach in biosimilarity assessment. However, the MATOST method using the conservative Holm and Bonferroni approaches is not favorable since it leads to a large sample size although it controls the type I error rate.Keywords: bioequivalence and biosimilarity, multiple references, simultaneous confidence interval approach, multiplicity-adjusted two one-sided tests, MATOSThttps://www.dovepress.com/comparison-of-innovative-and-conventional-methods-in-biosimilar-bridgi-peer-reviewed-fulltext-article-BTTbioequivalence and biosimilaritymultiple referencessimultaneous confidence interval approachmultiplicity-adjusted two one-sided testsmatost
spellingShingle Pong A
Chow SS
Chow SC
Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
Biologics: Targets & Therapy
bioequivalence and biosimilarity
multiple references
simultaneous confidence interval approach
multiplicity-adjusted two one-sided tests
matost
title Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
title_full Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
title_fullStr Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
title_full_unstemmed Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
title_short Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
title_sort comparison of innovative and conventional methods in biosimilar bridging studies with multiple references
topic bioequivalence and biosimilarity
multiple references
simultaneous confidence interval approach
multiplicity-adjusted two one-sided tests
matost
url https://www.dovepress.com/comparison-of-innovative-and-conventional-methods-in-biosimilar-bridgi-peer-reviewed-fulltext-article-BTT
work_keys_str_mv AT ponga comparisonofinnovativeandconventionalmethodsinbiosimilarbridgingstudieswithmultiplereferences
AT chowss comparisonofinnovativeandconventionalmethodsinbiosimilarbridgingstudieswithmultiplereferences
AT chowsc comparisonofinnovativeandconventionalmethodsinbiosimilarbridgingstudieswithmultiplereferences